Tend to agree R&J.......If the company had a decent chance of materially higher share prices, then I believe TK would have found a way to fund his options without having to sell.
Certainly disappointing given the positive macro overlay of Telehealth/remote healthcare + the lack of ASX companies to invest in, that leverage the positive thematic.
RAP Price at posting:
17.5¢ Sentiment: Hold Disclosure: Not Held